Episode
EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
- Podcast
- Lung Cancer Update
- Published
- Feb 6, 2025
- Duration seconds
- 3602
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/lung-cancer-update-827388/episodes/egfr-mutant-non-small-cell-lung-cancer-year-in-review-series-on-relevant-new-datasets-and-advances-2/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/lung-cancer-update-827388/egfr-mutant-non-small-cell-lung-cancer-year-in-review-series-on-relevant-new-datasets-and-advances-2.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Dr Enriqueta Felip from the Vall d’Hebron Institute of Oncology in Barcelona, Spain, and Dr Helena Yu from Memorial Sloan Kettering Cancer Center in New York, New York, discuss current and emerging treatment approaches for patients with EGFR-mutant non-small cell lung cancer. CME information and select publications here